Tsukuba, Japan

Yuta Sunadoi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: National Center of Neurology and Psychiatry, Nippon Shinyaku Company, Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuta Sunadoi. Retrieved from https://idiyas.com/inventor/yuta-sunadoi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuta Sunadoi: Innovator in Antisense Nucleic Acid Technology

Introduction

Yuta Sunadoi is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antisense nucleic acids. His work focuses on innovative solutions for genetic disorders, showcasing his dedication to advancing medical science.

Latest Patents

Yuta Sunadoi holds 1 patent for his invention titled "Antisense nucleic acid that induces skipping of exon 50." This patent presents a groundbreaking drug that facilitates highly efficient skipping of exon 50 in the human dystrophin gene. The antisense oligomer he developed plays a crucial role in this process, offering potential therapeutic benefits for individuals affected by related genetic conditions.

Career Highlights

Throughout his career, Yuta Sunadoi has worked with notable organizations, including Nippon Shinyaku Company, Ltd. and the National Center of Neurology and Psychiatry. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Yuta has collaborated with esteemed colleagues such as Yukiko Enya and Reiko Waki. Their joint efforts have furthered the understanding and application of antisense technology in treating genetic disorders.

Conclusion

Yuta Sunadoi's innovative work in antisense nucleic acid technology exemplifies his commitment to improving healthcare through scientific research. His contributions are paving the way for new therapeutic approaches to genetic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…